Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Amphista Therapeutics Ltd

Clinical trials sponsored by Amphista Therapeutics Ltd, explained in plain language.

Trials to join now! 1

Can a new oral drug take on hard-to-treat leukaemia?

Disease control Recruiting now

This early-stage trial is testing an experimental drug called AMX-883, taken by mouth, for people with acute myeloid leukaemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or not responded to standard treatments. The study will first test AMX-883 alone, th…

Phase 1 • Sponsor: Amphista Therapeutics Ltd • Aim: Disease control

Last updated Sep 17, 2026 00:00 UTC